Mertens, C.; Schnetz, M.; Rehwald, C.; Grein, S.; Elwakeel, E.; Weigert, A.; Brüne, B.; Jung, M.
Iron-Bound Lipocalin-2 from Tumor-Associated Macrophages Drives Breast Cancer Progression Independent of Ferroportin. Metabolites 2021, 11, 180.
https://doi.org/10.3390/metabo11030180
AMA Style
Mertens C, Schnetz M, Rehwald C, Grein S, Elwakeel E, Weigert A, Brüne B, Jung M.
Iron-Bound Lipocalin-2 from Tumor-Associated Macrophages Drives Breast Cancer Progression Independent of Ferroportin. Metabolites. 2021; 11(3):180.
https://doi.org/10.3390/metabo11030180
Chicago/Turabian Style
Mertens, Christina, Matthias Schnetz, Claudia Rehwald, Stephan Grein, Eiman Elwakeel, Andreas Weigert, Bernhard Brüne, and Michaela Jung.
2021. "Iron-Bound Lipocalin-2 from Tumor-Associated Macrophages Drives Breast Cancer Progression Independent of Ferroportin" Metabolites 11, no. 3: 180.
https://doi.org/10.3390/metabo11030180
APA Style
Mertens, C., Schnetz, M., Rehwald, C., Grein, S., Elwakeel, E., Weigert, A., Brüne, B., & Jung, M.
(2021). Iron-Bound Lipocalin-2 from Tumor-Associated Macrophages Drives Breast Cancer Progression Independent of Ferroportin. Metabolites, 11(3), 180.
https://doi.org/10.3390/metabo11030180